These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26091469)

  • 1. Specific Safety Profile of Bevacizumab in Asian Patients With Advanced NSCLC: A Meta-Analysis.
    Chen Z; Zhong B; Lun X; Lai Y; Bella AE; Yang W; Wu J
    Medicine (Baltimore); 2015 Jun; 94(24):e975. PubMed ID: 26091469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of first-line bevacizumab with chemotherapy in Asian patients with advanced nonsquamous NSCLC: results from the phase IV MO19390 (SAiL) study.
    Tsai CM; Au JS; Chang GC; Cheng AC; Zhou C; Wu YL
    J Thorac Oncol; 2011 Jun; 6(6):1092-7. PubMed ID: 21512405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of bevacizumab to chemotherapy in advanced non-small cell lung cancer: a systematic review and meta-analysis.
    Lima AB; Macedo LT; Sasse AD
    PLoS One; 2011; 6(8):e22681. PubMed ID: 21829644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer: an evidence-based approach.
    Tassinari D; Sartori S; Papi M; Drudi F; Castellani C; Carloni F; Tombesi P; Lazzari-Agli L
    Oncology; 2011; 80(5-6):350-8. PubMed ID: 21791945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer.
    Soria JC; Mauguen A; Reck M; Sandler AB; Saijo N; Johnson DH; Burcoveanu D; Fukuoka M; Besse B; Pignon JP;
    Ann Oncol; 2013 Jan; 24(1):20-30. PubMed ID: 23180113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of bevacizumab (Bev) plus chemotherapy (CT) compared to CT alone in previously untreated locally advanced or metastatic non-small cell lung cancer (NSCLC): systematic review and meta-analysis.
    Botrel TE; Clark O; Clark L; Paladini L; Faleiros E; Pegoretti B
    Lung Cancer; 2011 Oct; 74(1):89-97. PubMed ID: 21377753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab in non-small cell lung cancer.
    Di Costanzo F; Mazzoni F; Micol Mela M; Antonuzzo L; Checcacci D; Saggese M; Di Costanzo F
    Drugs; 2008; 68(6):737-46. PubMed ID: 18416583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of bevacizumab for unresectable non-small-cell lung cancer: a meta-analysis.
    Yang K; Wang YJ; Chen XR; Chen HN
    Clin Drug Investig; 2010; 30(4):229-41. PubMed ID: 20225906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer.
    Niho S; Kunitoh H; Nokihara H; Horai T; Ichinose Y; Hida T; Yamamoto N; Kawahara M; Shinkai T; Nakagawa K; Matsui K; Negoro S; Yokoyama A; Kudoh S; Kiura K; Mori K; Okamoto H; Sakai H; Takeda K; Yokota S; Saijo N; Fukuoka M;
    Lung Cancer; 2012 Jun; 76(3):362-7. PubMed ID: 22244743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bevacizumab combined with chemotherapy for advanced non-small cell lung cancer: a meta-analysis].
    Zhang T; Yuan S; Wang Z; Zhang Q; Zhao P; Shan L
    Zhongguo Fei Ai Za Zhi; 2013 Feb; 16(2):82-90. PubMed ID: 23425900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of bevacizumab plus cisplatin-based chemotherapy versus pemetrexed plus cisplatin treatment in East Asian non-squamous non-small cell lung cancer patients applying real-life outcomes.
    Chang GC; Ahn MJ; Wright E; Kim HT; Kim JH; Kang JH; Kim SW; Sherman S; Walzer S
    Asia Pac J Clin Oncol; 2011 Jun; 7 Suppl 2():34-40. PubMed ID: 21585706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study.
    Crinò L; Dansin E; Garrido P; Griesinger F; Laskin J; Pavlakis N; Stroiakovski D; Thatcher N; Tsai CM; Wu YL; Zhou C
    Lancet Oncol; 2010 Aug; 11(8):733-40. PubMed ID: 20650686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of bevacizumab with cisplatin and gemcitabine in Asian patients with advanced or recurrent non-squamous non-small cell lung cancer who have not received prior chemotherapy: a substudy of the Avastin in Lung trial.
    Mok TS; Hsia TC; Tsai CM; Tsang K; Chang GC; Chang JW; Sirisinha T; Sriuranpong V; Thongprasert S; Chua DT; Moore N; Manegold C
    Asia Pac J Clin Oncol; 2011 Jun; 7 Suppl 2():4-12. PubMed ID: 21585703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of bevacizumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase III BO17704 study (AVAiL).
    Leighl NB; Zatloukal P; Mezger J; Ramlau R; Moore N; Reck M; Manegold C
    J Thorac Oncol; 2010 Dec; 5(12):1970-6. PubMed ID: 20978447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer : analysis of the Italian patients enrolled in the SAiL study.
    Bearz A; Passalacqua R; Alabiso O; Cinieri S; Gridelli C; Cravesana C; Crinò L
    Clin Drug Investig; 2012 Nov; 32(11):755-60. PubMed ID: 23018280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab as first-line treatment for advanced non-small cell lung cancer.
    Socinski MA
    Drugs Today (Barc); 2008 Apr; 44(4):293-301. PubMed ID: 18536787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bevacizumab in the first-line therapy of advanced NSCLC].
    Hasenöhrl N
    Wien Med Wochenschr; 2007; 157(21-22):576-8. PubMed ID: 18157597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy: evidence from a meta-analysis of randomized control trials.
    Huang LT; Cao R; Wang YR; Sun L; Zhang XY; Guo YJ; Zhao JZ; Zhang SL; Jing W; Song J; Han CB; Ma J
    BMC Cancer; 2021 Apr; 21(1):426. PubMed ID: 33865364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging safety data for bevacizumab in advanced non-small-cell lung cancer.
    Hirsh V
    Clin Lung Cancer; 2008 Mar; 9 Suppl 2():S62-70. PubMed ID: 21885001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer.
    Yang ZY; Liu L; Mao C; Wu XY; Huang YF; Hu XF; Tang JL
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD009948. PubMed ID: 25400254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.